HighMark Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
HighMark Wealth Management's DGX Position: Q3 2026 in Review
HighMark Wealth Management opened a new position in Quest Diagnostics (DGX) in Q3 2026: 27 shares worth $6.29K. The stake represents ﹤0.01% of the portfolio and ranks #389 among its holdings. This is a return to the name: HighMark Wealth Management previously reported a position in DGX as recently as Q4 2022.
HighMark Wealth Management first reported a position in DGX in Q4 2019 and has held it in 14 quarters since. The position peaked at $40K in Q4 2021. 1,142 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- HighMark Wealth Management held 27 shares of Quest Diagnostics worth $6.29K as of Q3 2026.
- Quest Diagnostics was a new HighMark Wealth Management position in Q3 2026.
- Quest Diagnostics made up ﹤0.01% of HighMark Wealth Management's portfolio in Q3 2026, its #389 holding.
- HighMark Wealth Management first reported a position in Quest Diagnostics in Q4 2019 and has held it in 14 quarters since.
- HighMark Wealth Management's Quest Diagnostics position peaked at $40K in Q4 2021.
- 1,142 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on HighMark Wealth Management's 13F filing for Q3 2026, filed 17 Nov 2026.